KPRX – kiora pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Form SC 13G/A KIORA PHARMACEUTICALS Filed by: Stonepine Capital Management, LLC
Form SC 13G KIORA PHARMACEUTICALS Filed by: GOLDMAN SACHS GROUP INC
Form 8-K KIORA PHARMACEUTICALS For: Nov 08
Form 10-Q KIORA PHARMACEUTICALS For: Sep 30
Form 8-K KIORA PHARMACEUTICALS For: Oct 29
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.